It is therefore a possibility that both proteins S100A8 and S100A9 might be of particular relevance to hematological malignancies through their critical role in the progression of pre-leukemic states as myelodysplasic syndrome or myeloproliferative neoplasm. This evidence concerns the gene S100A8 and myeloproliferative neoplasm.